PostEra
Drug Discovery
PostEra valuation and funding history | Last updated: January 14, 2022 | 2 funding rounds
Current Valuation
N/A
As of January 14, 2022
Total Funding Raised
N/A
Across 2 rounds
Last Round
Early Stage VC (Series A)
$26.1M
Last Funding
Jan 2022
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| January 14, 2022 | Early Stage VC (Series A) | $26.1M | N/A | - |
| April 6, 2020 | Seed Round | $2.4M | N/A | - |
Valuation Analysis
Current Valuation Metrics
PostEra is currently valued at N/A as of January 14, 2022.
What is PostEra Worth in 2026?
PostEra is a leading private company in the Drug Discovery sector. Track PostEra's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How PostEra Valuation is Determined
Private company valuations like PostEra's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.